In a recent analysis, which included over 3400 patients, apoB was strongly associated with coronary disease, and, along with other non-classical lipoprotein biomarkers, apoB added value to the standard lipid panel when it came to CV risk [13]. This evidence concerns the gene APOB and coronary artery disorder.